NCT05105698 - Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

February 28, 2022

Study Completion Date

September 30, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

gemigliptin and dapagliflozin 50/10 mg film-coated tablet (Fasting)

Subjects will check-in a night before investigational product administration, supervised for at least 8 hours overnight fasting prior to dosing and in-house stay until 24 hours post-dose.(fasting)

DRUG

gemigliptin and dapagliflozin 50/10 mg film-coated tablet (fed)

Subjects will check-in a night before investigational product administration, supervised for at least 8 hours overnight fasting prior to dosing and in-house stay until 24 hours post-dose.(fed)